News | Computed Tomography (CT) | November 29, 2015

UBMD Orthopaedics & Sports Medicine investigating technology to acquire weight-bearing 3-D images of extremity injuries

Carestream, cone beam computed tomography, CBCT, RSNA 2015, clinical studies, UBMD Orthopaedics & Sports Medicine

Image courtesy of Carestream Health


November 29, 2015 — Specialists from UBMD Orthopaedics & Sports Medicine are  investigating Carestream’s cone beam computed tomography (CBCT) technology to capture images of patients with orthopedic conditions as part of ongoing clinical studies. The CBCT system will be on display at Carestream’s booth at the Radiological Society of North America (RSNA) conference, Nov. 29-Dec. 3 in Chicago. The CBCT system used in these studies is investigational and not available for commercial sale.

UBMD Orthopaedics & Sports Medicine and Carestream are conducting an institutional IRB-approved clinical study designed to help orthopedic surgeons more accurately and objectively diagnose the degree of instability of the patella (knee cap). Two of the challenges of this condition are identifying the cause of patella dislocation and then calculating the amount of correction that would be necessary when tibial tubercle transfer surgery is planned.

“We compare images obtained on a conventional CT scanner to those obtained on the prototype CBCT scanner while the patient is standing, the quadriceps is active and the knee is flexed to 30 degrees,” said John Marzo, M.D., a physician with UBMD Orthopaedics & Sports Medicine, associate professor of clinical orthopedics, School of Medicine & Biomedical Sciences, University at Buffalo and former medical director, Buffalo Bills.

“The orthopedic specialists involved in the clinical study are extremely satisfied with image quality from the CBCT scanner and have provided positive feedback on the benefits provided by the use of this technology for weight-bearing exams,” he added.

Another research project is attempting to validate computational measures of joint surface area of contact and joint surface pressure using weight-bearing images from the cone beam CT scanner.

These clinical studies and other research projects will help guide Carestream’s development of new CBCT systems with the goal of providing orthopedic solutions for hospitals, clinics and sports medicine providers that use less radiation than traditional CT; are compact and affordable; and could be used in a wide range of facilities.

For more information: www.carestream.com


Related Content

News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | Contrast Agents

April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...

Time April 23, 2026
arrow
News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
Subscribe Now